Physician profile
Roy E Hanks
NPI 1912997073
$29,153.92
in general payments reported to CMS, 2019-2025
24 companies · $39.02 in 2025
The $39.02 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,745 · 2020: $11K · 2021: $4,329 · 2022: $4,678 · 2023: $157 · 2024: $13.59 · 2025: $39.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $28,375.22 | 2019-2022 | |
| Allergan, INC. | $117.25 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.26 | 2021-2023 | Gattex |
| Kls-Martin L.P. | $77.21 | 2019-2022 | |
| Conmed Corporation | $53.47 | 2020-2021 | |
| Smith+Nephew, INC. | $48.57 | 2019-2021 | |
| Fresenius Kabi USA, LLC | $43.40 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $31.88 | 2023-2025 | Myrisk |
| Tela Bio, INC. | $31.79 | 2022 | |
| Innocoll Pharmaceuticals Limited | $28.45 | 2022 | |
| Abbvie INC. | $28.43 | 2022 | |
| Checkpoint Surgical, INC | $24.36 | 2023 | Checkpoint Stimulators |
| Convatec INC. | $23.91 | 2023 | |
| Novo Nordisk INC | $23.90 | 2025 | |
| Covidien LP | $22.59 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $21.48 | 2022 | |
| Zimmer Biomet Holdings, INC. | $18.52 | 2019 | |
| Exact Sciences Corporation | $16.96 | 2023 | Cologuard Collection Kit |
| Genentech USA, INC. | $16.56 | 2019 | |
| Braintree Laboratories, INC. | $16.07 | 2023 | Sutab, Suflave |
| Ethicon US, LLC | $16.03 | 2021 | |
| Medtronic, INC. | $13.59 | 2024 | Progrip |
| Atricure, INC. | $13.10 | 2021 | |
| Ibsa Pharma INC. | $12.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Hanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.